BSE filing, BSE: 544673. Summary written from the filing by ALFA Finder's alert engine.
Modern Diagnostic & Research Centre Ltd: key numbers
- Share price
- ₹59.30
- Market cap
- ₹89.54 Cr
- Revenue (annual)
- ₹83.11 Cr
- Net profit (annual)
- ₹5.25 Cr
- P/E (TTM)
- 17.0×Sector 52.0×
- Promoter holding
- 72.95%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Modern Diagnostic & Research Centre Ltd
All →Modern Diagnostic & Research Centre Other Announcement
The company submitted the Regulation 74(5) certificate for the half-year ended September 30, 2026, confirming depository participant compliance, alongside a nil investor grievance report.
Modern Diagnostic & Research Centre Annual General Meeting
Modern Diagnostic & Research Centre Limited conducted its 14th AGM on September 30, 2026. Shareholders transacted ordinary business, including the adoption of financial statements and auditor reappointment.
Modern Diagnostic & Research Centre Price Movement Clarification
Modern Diagnostic & Research Centre Ltd clarified its share price movement is purely market-driven. No undisclosed or price-sensitive information exists requiring disclosure under SEBI Regulations.
Modern Diagnostic & Research Centre Annual Report
Modern Diagnostic & Research Centre has submitted its Annual Report and Notice of the 14th Annual General Meeting for the financial year 2025-26.
Modern Diagnostic & Research Centre Annual General Meeting
Modern Diagnostic & Research Centre Limited has scheduled its 14th Annual General Meeting for September 30, 2026. The book closure is from September 24 to 30.
Modern Diagnostic & Research Centre Board Meeting Outcome
Modern Diagnostic & Research Centre approved various routine matters, including AGM notice, director reappointment, and statutory auditor reappointment. It also terminated a Jaipur laboratory management agreement.
Other board meeting date announcements
All →Dangee Dums Board Meeting Date
Dangee Dums will hold a board meeting on 2 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. Trading window closure runs until 4 November 2026.
Relic Technologies Board Meeting Date
Relic Technologies intimated a board meeting on 2 Nov 2026 to consider unaudited standalone and consolidated Q2 results for the period ended 30 Sep 2026. The trading window closes from 1 Oct 2026 until 48 hours after the results are disseminated.
EPL Board Meeting Date
EPL will hold a board meeting on November 4, 2026 to consider September quarter results. Trading window re-opens 48 hours after results are declared.
Chemplast Sanmar Board Meeting Date
Chemplast Sanmar will meet on 4 November 2026 to approve September quarter results. The trading window stays closed until 6 November 2026.
Kemistar Corporation Board Meeting Date
Kemistar Corporation scheduled a board meeting on 6 November 2026 to consider unaudited results. Trading window remains closed until 8 November 2026.
Rajasthan Cylinders & Containers Board Meeting Date
Rajasthan Cylinders & Containers intimated a board meeting on 05 November 2026 to approve unaudited results for quarter and half year ended 30 September 2026. The trading window stays closed until 07 November 2026.